Form D · Biotechnology

Organovo, Inc.

San Diego, CA · CIK 0001530838

Offering snapshot reported Nov 2, 2011 · SEC filing

Reported sold: $3.49M
Investors reported: 47
Minimum accepted: $0
First sale: Oct 13, 2011

Fundraising history

Reported sold

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

Reported investors57 → 47

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Nov 2, 2011	Amendment	$3,489,760	$0vs Oct 27, 2011	47	SEC filing
Oct 27, 2011	Initial	$3,489,760	No comparison	57	SEC filing
Sep 22, 2011	Initial	Yet to sell	No comparison	0	SEC filing

Offering details

Securities: Equity
Exemptions: 06
Duration over one year: No
Business combination: No

Sales commissions: $0
Finders' fees: $0
Form D file number: 021-167875

The equity securities offered were issued in exchange for the cancellation of then outstanding notes payable and accrued interest thereon.

Source: Form D, filed Nov 2, 2011. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Robert Baltera	Director
Sharon Collins Presnell	Executive
Gabor Forgacs	Director
Andras Forgacs	Director
Barry Michaels	Executive
Keith Murphy	Director, Executive, Promoter

Issuer details

Industry: Biotechnology (See others in industry)

Address:

5871 Oberlin Drive, Suite 150
San Diego, CA, 92121